Product Manager Liquid Handling
Product Manager Liquid Handling
Principal Director, Scientific Operations and Veterinary Science, Charles River
Manager, Research and Development
Associate Professor, Center for the Neurobiology of Stress Resilience and Psychiatric Disorders, Department of Cellular and Molecular Pharmacology, The Chicago Medical School,
Rosalind Franklin University of Medicine and Science
Field Applications Scientist Nucleic Acid Therapeutics Thermo Fisher Scientific
Senior Field Application Scientist, Sphere Fluidics Limited
Head of Product Management SYNTHIA™ Retrosynthesis Software, Digital Chemistry
Senior Scientist, Application Development
Field Software Trainer, QIAGEN Digital Insights
Senior Scientist, NeoGenomics Laboratories
Neuroscience Lead & Chair in Translational Neuroscience, School of Medicine, Medical Sciences & Nutrition, Institute of Medical Sciences, University of Aberdeen
Assistant Professor, Pharmacology, Midwestern University
Veterinarian and Biomedical Research Professor, College of Medicine, Gachon University
Assistant Professor, Pharmacology, Midwestern University
Associate Dean of Research and Professor, College of Pharmacy, Professor, College of Graduate Studies, Departments of Pharmacology and Biomedical Sciences, Director, Pharmacometrics Center of Excellence, Midwestern University
Global Product Manager for Sample Preparation, Miltenyi Biotec B.V. & CO. KG
Professor in Translational Proteomics, KTH Royal Institute of Technology
Business Development, AroCell AB
Scientist, CN-Bio
Application Development Scientist Liquid Handling
Scientist, CN-Bio Innovations
Senior Scientist, Scientific Manager Multiplexing, NeoGenomics Labroatories, Inc.
Experience the forefront of pharmaceutical innovation as Labroots and the Drug Discovery and Development planning committee host the 7th Annual Event in the Drug Discovery & Development Virtual Event Series on February 21st, 2024. Join industry and academic leaders to explore the latest breakthroughs, challenges, and successes in this ever-evolving field.
The 2024 program agenda covers a wide range of tracks and topics, including Emerging Modalities in Drug Discovery and Preclinical Development covering emerging assays, in-vitro models of toxicity, and predicting safety and efficacy. In the New Methods in Phamacogenomics track our expert speakers dive into the PGX of GPCRs, organoid models, and novel microphysiological systems. In-depth discussions of Biomarker Applications focus on innovations, digital solutions, and omics applications. Finally, our speakers elucidate the complexities of this broad and evolving field with a track dedicated to Advancing the Art: Improving Drug Discovery Methodology.
Mark your calendars and join us for a full day of innovation and knowledge sharing at this transformative virtual event!
Emerging Modalities in Drug Discovery and Preclinical Development
New Methods in Phamacogenomics
Biomarker Applications
Advancing the Art: Improving Drug Discovery Methodology
Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2024 Drug Discovery & Development Virtual Event. Submission is free. Submit your abstract here.
Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open for 2 years from the date of the live event, and the webinars will be available for unlimited on-demand viewing. This virtual conference also offers increased reach for the global drug discovery community with a high degree of interaction through live-streaming video and chat sessions.
Connect with us!
When you attend the event remember to use the hashtag #LRdrug to follow the conversation and connect with other members of the global Drug Discovery & Development community! Follow @DrugDiscoveryLR on Twitter and @DrugDiscoveryandDevelopment on Facebook to connect with our specialist Drug Discovery & Development writers and stay up to date with the latest Trending News in Drug Discovery & Development.
You can now also join our Drug Discovery, Development, & Therapeutics professional networking group on LinkedIn!
Labroots is a proud partner of Chati, a virtual event platform that allows for the hosting of engaging and interactive virtual and hybrid events, catering to businesses of any vertical or size.
Continuing Education
Labroots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving ...
See moreThe Sartorius Group is a leading international partner of biopharmaceutical research and the industry. With innovative laboratory instruments and consumables, the Group's Lab Products & Services Division concentrates on serving the needs of laboratories performing research and ...
See moreFor over 30 years, Miltenyi Biotec has been a leader in the development of products that empower the advancement of biomedical research and enable cell and gene therapy. We provide innovative tools to help with your sample preparation, cell isolation, cell culture, and cell ...
See moreThe speakers below have been approved for Continuing Education Credits. To redeem your credits, locate the presentation you watched and click on the CE buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here
Dr. Shaifali Bhalla is Associate Professor of Pharmaceutical Sciences and Associate Dean of Administrative Affairs at Midwestern University College of Pharmacy, Downers Grove, IL. She received her Ph.D. from the University of Illinois at Chicago, USA in 2005. Dr. Bhalla's ...
See moreAudrey is an experienced researcher in microbiology, parasitology with significant experience in molecular biology and 3D mammalian cell culture. As Product Manager, she is responsible for CN Bio's PhysioMimix™ Organ-on-a-chip systems and their implementation in research ...
See moreMatt entered the research field over 20 years ago as a lab animal technician at the TSI/Mason contract research facility. He has worked at both contract facilities such as TSI and OREAD Biosafety as well in industry at Pharmacia, Pfizer, and Sanofi-Aventis. During that period he ...
See moreBetween 1994-2015 he worked at EKF Diagnostics in Wales (formerly Argutus Medical) where he introduced and promoted a wide range of novel kidney and liver tests, including important biomarkers that are now being evaluated by the IMI (Innovative Medicines Initiative) and FDA as ...
See moreOver the past 16 years, Mr. Shipton has amassed deep domain expertise in cell-based products and services. Currently serving as President of Novabiosis, Inc. Mr. Shipton brings a skill for implementing sales-driven business strategies, an extensive track record of meeting and ...
See moreDr. Qingyan Sandy Au is Director of Multiplexing at NeoGenomics. In this role, She is responsible for overall scientific and operational function of Multiplexing modality including MultiOmyxTM , PhenoImagerTM, Rarecyte CTC technology platforms and imaging analysis. She has over ...
See moreDr. Marsha Pierce is an assistant professor at Midwestern University where she studies the role of marine natural products in neuroscience drug development. Dr. Pierce received her BS in biology and MS and PhD in biomedical sciences at Creighton University. Her postdoctoral ...
See more